Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia
Show others and affiliations
Number of Authors: 9
2015 (English)In: Haematologica (online), ISSN 0390-6078, E-ISSN 1592-8721, Vol. 100, no 6, E223-E225 p.Article in journal, Letter (Refereed) Published
Place, publisher, year, edition, pages
2015. Vol. 100, no 6, E223-E225 p.
Keyword [en]
myelodysplastic syndromes, acute myeloid leukemia, secondary, therapy-related, high-throughput mutational screening
National Category
Hematology
Identifiers
URN: urn:nbn:se:su:diva-120482DOI: 10.3324/haematol.2014.118034ISI: 000358577000003OAI: oai:DiVA.org:su-120482DiVA: diva2:853215
Available from: 2015-09-11 Created: 2015-09-10 Last updated: 2017-12-05Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Unneberg, Per
By organisation
Department of Biochemistry and BiophysicsScience for Life Laboratory (SciLifeLab)
In the same journal
Haematologica (online)
Hematology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 42 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf